Author: Saba Ismail; Sajjad Ahmad; Syed Sikander Azam
Title: Immuno-informatics Characterization SARS-CoV-2 Spike Glycoprotein for Prioritization of Epitope based Multivalent Peptide Vaccine Document date: 2020_4_12
ID: 3jmo35jc_32
Snippet: Further, disulfide engineering of the MEPVC was performed in order to optimize molecular interactions and confer considerable stability by attaining precise geometric conformation [89, 90] . Eight pairs of residues were selected to be replaced with cysteine amino acid. These pairs are: Gln7-Ala19 (χ3 angle,+118, energy value, 4.20 kcal/mol), Cys18-Leu21 (χ3 angle,+84.35, energy value, 3.69 kcal/mol), Lys44-Ala47 (χ3 angle,+74.17, energy value,.....
Document: Further, disulfide engineering of the MEPVC was performed in order to optimize molecular interactions and confer considerable stability by attaining precise geometric conformation [89, 90] . Eight pairs of residues were selected to be replaced with cysteine amino acid. These pairs are: Gln7-Ala19 (χ3 angle,+118, energy value, 4.20 kcal/mol), Cys18-Leu21 (χ3 angle,+84.35, energy value, 3.69 kcal/mol), Lys44-Ala47 (χ3 angle,+74.17, energy value,5.59 kcal/mol), Arg57-Ala61 (χ3 angle,+122.71 , energy value,6.14 kcal/mol), Ala72-Ala85 (χ3 angle,-62.92, energy value,4.40 kcal/mol), Ala73-Ala82 (χ3 angle, , energy value, kcal/mol), Leu92-Glu95 (χ3 angle, -102.37 , energy value, 3.86 kcal/mol), and Phe111-Pro117 (χ3 angle,-96.20 , energy value,4.14 kcal/mol). These residues have either higher energy level i.e. > 2 kcal/mol and χ3 angle out of range (< −87 and > + 97) were selected on purpose to make them stable. The original and disulfide mutant MEPVC structures are shown in Fig.6 . The primary purpose of in silico cloning of the MEPVC was guide molecular biologist and genetic engineers about the possible cloning sites and predicted level of expression in a specific expression system for instance here in this study we used E. coli K12 system. Prior to cloning, reverse translation of the MEPVC sequence was conducted to have an optimized codon usage as per E. coli K12 to yield its max expression. The CAI value of the improved MEPVC sequence is 1 indicating ideal expression of the vaccine [91] . The GC content whereas is 53.2 % nearly to the E. coli K12 and range within the optimum ranged between 30 % and 70%. The cloned MEPVC is shown in Fig.7. . author/funder. All rights reserved. No reuse allowed without permission.
Search related documents:
Co phrase search for related documents- amino acid and clone site: 1
- amino acid and codon usage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- amino acid and considerable stability: 1
- amino acid and cysteine amino acid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- amino acid and disulfide engineering: 1
- amino acid and energy value: 1, 2, 3, 4, 5, 6
- amino acid and expression level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- amino acid and expression system: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- amino acid and GC content: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- CAI value and codon usage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- CAI value and expression level: 1, 2
- CAI value and expression system: 1, 2, 3
- CAI value and GC content: 1, 2, 3, 4, 5, 6
- codon usage and cysteine amino acid: 1
- codon usage and expression level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- codon usage and expression system: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- codon usage and GC content: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- disulfide engineering and energy value: 1
- disulfide engineering and expression system: 1
Co phrase search for related documents, hyperlinks ordered by date